1 |
ZHAO Y, LING Z, HAO Y, et al. MiR-124 acts as a tumor suppressor by inhibiting the expression of sphingosine kinase 1 and its downstream signaling in head and neck squamous cell carcinoma[J]. Oncotarget, 2017, 8(15): 25005-25020.
|
2 |
HII L W, CHUNG F F, MAI C W, et al. Sphingosine Kinase 1 Signaling in Breast Cancer: A Potential Target to Tackle Breast Cancer Stem Cells[J]. Front Mol Biosci, 2021, 8: 748470.
|
3 |
MA Y, XING X, KONG R, et al. SphK1 promotes development of non‑small cell lung cancer through activation of STAT3[J]. Int J Mol Med, 2021, 47(1): 374-386.
|
4 |
曹宇华,殷舞,吕艳茹. 敲低鞘氨醇激酶-1对非小细胞肺癌细胞增殖及线粒体凋亡途径的影响及机制[J]. 生理学报,2021,73(6):893-900.
|
5 |
LI P H, WU J X, ZHENG J N, et al. A sphingosine kinase-1 inhibitor, SKI-II, induces growth inhibition and apoptosis in human gastric cancer cells[J]. Asian Pac J Cancer Prev, 2014, 15(23): 10381-10385.
|
6 |
LI W, LI J, WANG Y, et al. Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma[J]. Oncotarget, 2016, 7(49): 80586-80598.
|
7 |
SUKOCHEVA O A. Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming[J]. Int J Mol Sci, 2018, 19(2):420.
|
8 |
TAN S S, KHIN L W, WONG L, et al. Sphingosine kinase 1 promotes malignant progression in colon cancer and independently predicts survival of patients with colon cancer by competing risk approach in South asian population[J]. Clin Transl Gastroenterol, 2014, 5(2): e51.
|
9 |
LONG J, YAO Z, SUI Y, et al. SphK1 Promotes Cancer Progression through Activating JAK/STAT Pathway and Up-Regulating S1PR1 Expression in Colon Cancer Cells[J]. Anticancer Agents Med Chem, 2022, 22(2): 254-260.
|
10 |
LI Q, LI X, YANG X, et al. Long Intergenic Nonprotein Coding RNA 173 Inhibits Tumor Growth and Promotes Apoptosis by Repressing Sphingosine Kinase 1 Protein Expression in Pancreatic Cancer[J]. DNA Cell Biol, 2021, 40(6): 757-775.
|
11 |
LU P H, CHEN M B, LIU Y Y, et al. Identification of sphingosine kinase 1 (SphK1) as a primary target of icaritin in hepatocellular carcinoma cells[J]. Oncotarget, 2017, 8(14): 22800-22810.
|
12 |
POWELL J A, LEWIS A C, ZHU W, et al. Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia[J]. Blood, 2017, 129(6): 771-782.
|
13 |
TAMASHIRO P M, FURUYA H, SHIMIZU Y, et al. Sphingosine kinase 1 mediates head & neck squamous cell carcinoma invasion through sphingosine 1-phosphate receptor 1[J]. Cancer Cell Int, 2014, 14(1): 76.
|
14 |
BONICA J, CLARKE C J, OBEID L M, et al. Upregulation of sphingosine kinase 1 in response to doxorubicin generates an angiogenic response via stabilization of Snail[J]. FASEB J, 2023, 37(3): e22787.
|
15 |
XU C Y, LIU S Q, QIN M B, et al. SphK1 modulates cell migration and EMT-related marker expression by regulating the expression of p-FAK in colorectal cancer cells[J]. Int J Mol Med, 2017, 39(5): 1277-1284.
|
16 |
WU J N, LIN L, LUO S B, et al. SphK1-driven autophagy potentiates focal adhesion paxillin-mediated metastasis in colorectal cancer[J]. Cancer Med, 2021, 10(17): 6010-6021.
|
17 |
LIU H, MA Y, HE H W, et al. SPHK1 (sphingosine kinase 1) induces epithelial-mesenchymal transition by promoting the autophagy-linked lysosomal degradation of CDH1/E-cadherin in hepatoma cells[J]. Autophagy, 2017, 13(5): 900-913.
|
18 |
ZENG Y, YAO X, CHEN L, et al. Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7/ syndecan-1/TGF-beta autocrine loop[J]. Oncotarget, 2016, 7(39): 63324-63337.
|
19 |
KAWAHARA S, OTSUJI Y, NAKAMURA M, et al. Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells[J]. Anticancer Drugs, 2013, 24(5): 473-483.
|
20 |
PATEL D S, AHMAD F, SNEINEH M ABU, et al. The Importance of Sphingosine Kinase in Breast Cancer: A Potential for Breast Cancer Management[J]. Cureus, 2021, 13(2): e13413.
|
21 |
BEACH J A, ASPURIA P J, CHEON D J, et al. Sphingosine kinase 1 is required for TGF-beta mediated fibroblastto- myofibroblast differentiation in ovarian cancer[J]. Oncotarget, 2016, 7(4): 4167-4182.
|
22 |
SATYANANDA V, OSHI M, TOKUMARU Y, et al. Sphingosine 1-phosphate (S1P) produced by sphingosine kinase 1 (SphK1) and exported via ABCC1 is related to hepatocellular carcinoma (HCC) progression[J]. Am J Cancer Res, 2021, 11(9): 4394-4407.
|
23 |
TSUCHIDA J, NAGAHASHI M, NAKAJIMA M, et al. Sphingosine Kinase 1 is Associated With Immune Cell-Related Gene Expressions in Human Breast Cancer[J]. J Surg Res, 2020, 256: 645-656.
|
24 |
LI H, XING X, ZHANG X, et al. Effects of triptolide on the sphingosine kinase-Sphingosine-1-phosphate signaling pathway in colitis-associated colon cancer[J].Int Immunopharmacol, 2020, 88: 106892.
|
25 |
LI L, WANG D, XIN S, et al. Sphingosine Kinase 1 Acts as a Hypoxia-Upregulated Oncogene to Regulate Cell Invasion and Resistance to NK Cell Killing in Bladder Carcinoma Cells[J]. Ann Clin Lab Sci, 2022, 52(5): 763-771.
|
26 |
ACHARYA S, YAO J, LI P, et al. Sphingosine Kinase 1 Signaling Promotes Metastasis of Triple-Negative Breast Cancer[J]. Cancer Res, 2019, 79(16): 4211-4226.
|
27 |
NAGAHASHI M, YAMADA A, KATSUTA E, et al. Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis[J]. Cancer Res, 2018, 78(7): 1713-1725.
|
28 |
STAYROOK K R, MACK J K, CERABONA D, et al. TGFbeta-Mediated induction of SphK1 as a potential determinant in human MDA-MB-231 breast cancer cell bone metastasis[J]. Bonekey Rep, 2015, 4: 719.
|
29 |
YIN S, MIAO Z, TAN Y, et al. SPHK1-induced autophagy in peritoneal mesothelial cell enhances gastric cancer peritoneal dissemination[J]. Cancer Med, 2019, 8(4): 1731-1743.
|
30 |
ELASBALI A M, Al-SOUD W A, ALHASSAN H H, et al. Discovering Gummadiol and Isoarboreol as potential inhibitors of sphingosine kinase 1: virtual screening and MD simulation studies[J]. J Biomol Struct Dyn, 2023, 1-9.
|